Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B

EMBO Journal

Volumn 26, Issue 24, 2007, Pages 5131-5142

  Gillet, Laurent ^a,b   Stevenson, Philip G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Antibody; Glycoprotein; Immune evasion; Virus

Indexed keywords

ANTISERUM; EPITOPE; GLYCAN; GLYCOPROTEIN B; NEUTRALIZING ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GLYCOSYLATION; HERPES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; VIRION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENIC MODULATION; CELL LINE; FEMALE; GENOME, VIRAL; HERPESVIRIDAE INFECTIONS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; NEUTRALIZATION TESTS; PLANT LECTINS; POLYSACCHARIDES; RHADINOVIRUS; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS REPLICATION;

HERPESVIRIDAE; MAMMALIA; MURID HERPESVIRUS 4;

EID: 37149005032     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/sj.emboj.7601925     Document Type: Article

References (57)

1. Adler H, Messerle M, Wagner M, Koszinowski UH (2000) Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74: 6964-6974
2. Akula SM, Pramod NP, Wang FZ, Chandran B (2002) Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108: 407-419
3. Atalay R, Zimmermann A, Wagner M, Borst E, Benz C, Messerle M, Hengel H (2002) Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 76: 8596-8608
4. Auerbach MR, Czajak SC, Johnson WE, Desrosiers RC, Alexander L (2000) Species specificity of macaque rhadinovirus glycoprotein B sequences. J Virol 74: 584-590
5. Balzarini J (2006) Inhibition of HIV entry by carbohydrate-binding proteins. Antiviral Res 71: 237-247
6. Basgoz N, Qadri I, Navarro D, Sears A, Lennette E, Youngblom J, Pereira L (1992) The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. J Gen Virol 73: 983-988
7. Bennett NJ, May JS, Stevenson PG (2005) Gamma-herpesvirus latency requires Tcell evasion during episome maintenance. PLoS Biol 3: e120
8. Boname JM, de Lima BD, Lehner PJ, Stevenson PG (2004) Viral degradation of the MHC class I peptide loading complex. Immunity 20: 305-317
9. Burton DR, Stanfield RL, Wilson IA (2005) Antibody versus HIV in a clash of evolutionary titans. Proc Natl Acad Sci USA 102: 14943-14948
10. Coleman HM, de Lima B, Morton V, Stevenson PG (2003) Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol 77: 2410-2417
11. de Lima BD, May JS, Stevenson PG (2004) Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol 78: 5103-5112
12. Dialyna IA, Graham D, Rezaee R, Blue CE, Stavrianeas NG, Neisters HG, Spandidos DA, Blackbourn DJ (2004) Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro. AIDS 18: 1263-1270
13. Dingwell KS, Brunetti CR, Hendricks RL, Tang Q, Tang M, Rainbow AJ, Johnson DC (1994) Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol 68: 834-845
14. Forrester A, Farrell H, Wilkinson G, Kaye J, Davis-Poynter N, Minson T (1992) Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol 66: 341-348
15. Gill MB, Gillet L, Colaco S, May JS, de Lima BD, Stevenson PG (2006) Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies. J Gen Virol 87: 1465-1475
16. Gillet L, Adler H, Stevenson PG (2007a) Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS ONE 2: e347
17. Gillet L, Gill MB, Colaco S, Smith CM, Stevenson PG (2006) Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J Gen Virol 87: 3515-3527
18. Gillet L, May JS, Colaco S, Stevenson PG (2007b) The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS ONE 2: e705
19. Gillet L, May JS, Colaco S, Stevenson PG (2007c) Glycoprotein L disruption reveals two functional forms of the murine gammaherpesvirus 68 glycoprotein H. J Virol 81: 280-291
20. Gillet L, May JS, Stevenson PG (2007d) Post-exposure vaccination improves gammaherpesvirus neutralization. PLoS ONE 2: e899
21. Gyselink R, Coles D, Ash RJ, Fritz ME (1978) Salivary neutralizing activity against herpes simplex virus type 1. J Infect Dis 137: 583-586
22. Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC (2006) Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313: 217-220
23. Holloway SA, Studdert MJ, Drummer HE (1998) Characterization of glycoprotein B of the gammaherpesvirus equine herpesvirus-2. J Gen Virol 79: 1619-1629
24. Inada T, Chong KT, Mims CA (1985) Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J Gen Virol 66: 871-878
25. Janz A, Oezel M, Kurzeder C, Mautner J, Pich D, Kost M, Hammerschmidt W, Delecluse HJ (2000) Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol 74: 10142-10152
26. Jiang R, Scott RS, Hutt-Fletcher LM (2006) Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42. J Virol 80: 7281-7283
27. Johnson DC, Feenstra V (1987) Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol 61: 2208-2216
28. Knossow M, Skehel JJ (2006) Variation and infectivity neutralization in influenza. Immunology 119: 1-7
29. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497
30. Laquerre S, Argnani R, Anderson DB, Zucchini S, Manservigi R, Glorioso JC (1998) Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol 72: 6119-6130
31. Lopes FB, Colaco S, May JS, Stevenson PG (2004) Characterization of the MuHV-4 glycoprotein B. J Virol 78: 13370-13375
32. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168: 1210-1226
33. Mardberg K, Nystrom K, Tarp MA, Trybala E, Clausen H, Bergstrom T, Olofsson S (2004) Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity. Glycobiology 14: 571-581
34. May JS, Colaco S, Stevenson PG (2005) Glycoprotein M is an essential lytic replication protein of the murine gammaherpesvirus 68. J Virol 79: 3459-3467
35. Mozdzanowska K, Feng J, Gerhard W (2003) Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice. J Virol 77: 8322-8328
36. Nagashunmugam T, Lubinski J, Wang L, Goldstein LT, Weeks BS, Sundaresan P, Kang EH, Dubin G, Friedman HM (1998) In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 72: 5351-5359
37. Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CA (1993) Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol 67: 703-710
38. Okazaki K, Fujii S, Takada A, Kida H (2006) The amino-terminal residue of glycoprotein B is critical for neutralization of bovine herpesvirus 1. Virus Res 115: 105-111
39. Patton S, Gendler SJ, Spicer AP (1995) The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim Biophys Acta 1241: 407-423
40. Peeters B, Pol J, Gielkens A, Moormann R (1993) Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. J Virol 67: 170-177
41. Rosa GT, Gillet L, Smith CM, de Lima BD, Stevenson PG (2007) IgG fc receptors provide an alternative infection route for murine gamma-herpesvirus- 68. PLoS ONE 2: e560
42. Rudiger H, Gabius HJ (2001) Plant lectins: occurrence, biochemistry, functions and applications. Glycoconj J 18: 589-613
43. Sissons JG, Oldstone MB (1980) Killing of virus-infected cells: the role of antiviral antibody and complement in limiting virus infection. J Infect Dis 142: 442-448
44. Sitki-Green D, Covington M, Raab-Traub N (2003) Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 77: 1840-1847
45. Stevenson PG, Belz GT, Castrucci MR, Altman JD, Doherty PC (1999) A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci USA 96: 9281-9286
46. Stevenson PG, Doherty PC (1998) Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol 72: 943-949
47. Stevenson PG, May JS, Smith XG, Marques S, Adler H, Koszinowski UH, Simas JP, Efstathiou S (2002) K3-mediated evasion of CD8(+) Tcells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3: 733-740
48. Tamura T, Chiba S, Chiba Y, Nakao T (1980) Virus excretion and neutralizing antibody response in saliva in human cytomegalovirus infection. Infect Immun 29: 842-845
49. Thorley-Lawson DA, Poodry CA (1982) Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol 43: 730-736
50. Turk SM, Jiang R, Chesnokova LS, Hutt-Fletcher LM (2006) Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol 80: 9628-9633
51. Vanderplasschen A, Markine-Goriaynoff N, Lomonte P, Suzuki M, Hiraoka N, Yeh JC, Bureau F, Willems L, Thiry E, Fukuda M, Pastoret PP (2000) A multipotential beta-1,6-N-acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4. Proc Natl Acad Sci USA 97: 5756-5761
52. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Weck KE, Dal Canto AJ, Speck SH (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71: 5894-5904
53. Wilson R, Chen C, Ratcliffe NA (1999) Innate immunity in insects: the role of multiple, endogenous serum lectins in the recognition of foreign invaders in the cockroach, Blaberus discoidalis. J Immunol 162: 1590-1596
54. Xu J, Lyons PA, Carter MD, Booth TW, Davis-Poynter NJ, Shellam GR, Scalzo AA (1996) Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol 77: 49-59
55. Yao QY, Rickinson AB, Epstein MA (1985) A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 35: 35-42
56. Yao QY, Rowe M, Morgan AJ, Sam CK, Prasad U, Dang H, Zeng Y, Rickinson AB (1991) Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization. Int J Cancer 48: 45-50
57. Zinkernagel RM, Hengartner H (2006) Protective 'immunity' by preexistent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'. Immunol Rev 211: 310-319